• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2023 Earnings

    3/13/24 7:02:00 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary
    Get the next $WOOF alert in real time by email

    Q4 2023 Highlights

    • Net revenue of $1.7 billion increased 6.1 percent year over year including the 14th week
    • Comparable sales declined 0.9 percent year over year and increased 4.4 percent on a two-year basis
    • GAAP net loss of $22.6 million, or $(0.08) per share, compared to GAAP net income of $32.7 million, or $0.12 per share in the prior year
    • Adjusted Net Income1 of $6.1 million, or $0.02 per share, compared to $52.8 million, or $0.20 per share in the prior year
    • Adjusted EBITDA1 of $105.3 million compared to $157.9 million in the prior year
    • Operating Cash Flow of $47.0 million compared to $136.5 million in the prior year
    • Free Cash Flow1 of $(2.0) million compared to $70.6 million in the prior year

    Full Year 2023 Highlights

    • Net revenue of $6.3 billion increased 3.6 percent year over year including the 53rd week
    • Comparable sales increased 1.8 percent year over year and increased 6.3 percent on a two-year basis
    • GAAP net loss of $1.3 billion, or $(4.78) per share, which includes goodwill impairment of $1.2B, compared to GAAP net income of $90.8 million, or $0.34 per share in the prior year
    • Adjusted Net Income1 of $22.8 million, or $0.09 per share, compared to $162.6 million, or $0.61 per share in the prior year
    • Adjusted EBITDA1 of $401.1 million compared to $530.8 million in the prior year
    • Operating Cash Flow of $215.7 million compared to $346.0 million in the prior year
    • Free Cash Flow1 of $(9.9) million compared to $68.0 million in the prior year

    SAN DIEGO, March 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), a complete partner in pet health and wellness, today announced its fourth quarter and full year 2023 financial results.       

    Petco (PRNewsFoto/Petco)

    In the fourth quarter of 2023, Petco delivered net revenue of $1.7 billion, up 6.1 percent versus prior year, inclusive of a 14th week. On an as-reported basis, the company's consumables business was up 8.8 percent versus prior year, and services and other business was up 17.4 percent versus prior year. Growth in the company's consumables and services and other business was partially offset by the company's supplies and companion animal business, down 1.4 percent versus prior year. GAAP net loss in the fourth quarter of 2023 was $22.6 million or $(0.08) per share, compared to GAAP net income of $32.7 million or $0.12 per share in the prior year. Adjusted Net Income1 was $6.1 million or $0.02 per share, compared to $52.8 million or $0.20 per share in the prior year. Adjusted EBITDA1 was $105.3 million compared to $157.9 million in the prior year.

    For the full year 2023, Petco delivered net revenue of $6.3 billion, up 3.6 percent versus prior year, inclusive of a 53rd week. On an as-reported basis, the company's consumables business was up 7.1 percent versus prior year, and services and other business was up 21.9 percent versus prior year. Growth in the company's consumables and services and other business was partially offset by its supplies and companion animal business, down 6.8 percent versus prior year. GAAP net loss of $1.3 billion or $(4.78) per share was inclusive of a goodwill impairment of $1.2B, compared to GAAP net income of $90.8 million or $0.34 per share in the prior year. Adjusted Net Income1 was $22.8 million or $0.09 per share, compared to $162.6 million or $0.61 per share in the prior year. Adjusted EBITDA1 was $401.1 million compared to $530.8 million in the prior year.

    (1)

    Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share ("Adjusted EPS"), and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

    Given the change in leadership, the company is not providing full year revenue, Adjusted EBITDA and Adjusted EPS guidance at this time. Instead, the company is providing earnings guidance for fiscal Q1. The company continues to provide interest, share count, and capital expenditure expectations for the full year.

    Fiscal Q1 2024 Outlook

    For Fiscal Q1 2024, the company expects:

    Metric*

    FQ1 2024

    Guidance

    Net Revenue

    ~ $1.5 billion

    Adjusted EBITDA    

    ~ $70 million

    Adjusted EPS

    ~ $(0.06)

    Fiscal 2024 Outlook

    For Fiscal 2024 (a 52-week year), the company expects:

    Metric*

    2024

    Guidance, YoY

    Net interest expense      

    ~$145 million

    Capital Expenditures

    ~$140 million

    *Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. For fiscal 2024, our guidance anticipates a 26 percent tax rate, and 272 million weighted average diluted share count.  Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

    Earnings Conference Call Webcast Information:

    Management will host an earnings conference call on March 13, 2024 at 8:00 AM Eastern Time to discuss the company's financial results. The conference call will be accessible through a live webcast. Interested  investors and other individuals can access the webcast, earnings release, earnings presentation, infographic, and earnings supplement via the company's investor relations page at ir.petco.com. A replay of the webcast will be archived on the company's investor relations page through March 27, 2024 until approximately 5:00 PM Eastern Time.

    About Petco, The Health + Wellness Co.:

    Founded in 1965, Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. We've consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 pet care centers across the U.S., Mexico and Puerto Rico, which offer merchandise, companion animals, grooming, training and a growing network of on-site veterinary hospitals and mobile veterinary clinics. Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app. In tandem with Petco Love, a life-changing organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for nearly 7 million animals.

    Forward-Looking Statements:

    This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including, but not limited to, statements regarding our Q1 and fiscal year 2024 guidance, operational reset of our business, our competitive positioning, profitability, cost action plans and associated cost-savings. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation and prevailing interest rates; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflict in Ukraine), health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; (xx) impairments of the carrying value of our goodwill and other intangible assets; (xxi) our ability to successfully implement our operational adjustments, achieve the expected benefits of our cost action plans and drive improved profitability; and (xxii) the other risks, uncertainties and other factors identified under "Risk Factors"  and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

    Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.





























    PETCO HEALTH AND WELLNESS COMPANY, INC.



    CONSOLIDATED STATEMENTS OF OPERATIONS



    (In thousands, except per share amounts)



    (Unaudited and subject to reclassification)



































    14 Weeks

    Ended



    13 Weeks

    Ended







    53 Weeks

    Ended



    52 Weeks

    Ended











    February 3,

    2024



    January 28,

    2023



    Percent

    Change



    February 3,

    2024



    January 28,

    2023



    Percent

    Change



    Net sales:



























    Products



    $     1,420,713



    $     1,361,856



    4 %



    $     5,273,710



    $     5,230,515



    1 %



    Services and other



    253,763



    216,103



    17 %



    981,574



    805,452



    0



    Total net sales



    1,674,476



    1,577,959



    6 %



    6,255,284



    6,035,967



    4 %



    Cost of sales:



























    Products



    903,156



    805,938



    12 %



    3,269,628



    3,035,249



    8 %



    Services and other



    164,972



    144,742



    14 %



    631,821



    573,611



    10 %



    Total cost of sales



    1,068,128



    950,680



    12 %



    3,901,449



    3,608,860



    8 %



    Gross profit



    606,348



    627,279



    (3 %)



    2,353,835



    2,427,107



    (3 %)



    Selling, general and administrative expenses



    606,182



    549,719



    10 %



    2,311,625



    2,201,548



    5 %



    Goodwill and indefinite-lived intangible impairment



    —



    —



    N/M



    1,222,524



    —



    N/M



    Operating income (loss)



    166



    77,560



    (100 %)



    (1,180,314)



    225,559



    N/M



    Interest income



    (326)



    (745)



    (56 %)



    (3,405)



    (1,032)



    230 %



    Interest expense



    39,658



    32,882



    21 %



    150,909



    101,643



    48 %



    Loss on extinguishment and modification of debt



    —



    —



    N/M



    920



    —



    N/M



    Other non-operating loss (income)



    —



    3,298



    (100 %)



    (4,727)



    12,667



    N/M



    (Loss) income before income taxes and income from

       equity method investees



    (39,166)



    42,125



    N/M



    (1,324,011)



    112,281



    N/M



    Income tax (benefit) expense



    (10,435)



    14,548



    N/M



    (27,613)



    35,347



    N/M



    Income from equity method investees



    (6,156)



    (5,155)



    19 %



    (16,188)



    (12,976)



    25 %



    Net (loss) income



    (22,575)



    32,732



    N/M



    (1,280,210)



    89,910



    N/M



    Net loss attributable to noncontrolling interest



    —



    —



    N/M



    —



    (891)



    (100 %)



    Net (loss) income attributable to Class A and B-1 common

       stockholders



    $           (22,575)



    $             32,732



    N/M



    $     (1,280,210)



    $             90,801



    N/M































    Net (loss) income per Class A and B-1 common share:



























    Basic



    $            (0.08)



    $             0.12



    N/M



    $            (4.78)



    $             0.34



    N/M



    Diluted



    $            (0.08)



    $             0.12



    N/M



    $            (4.78)



    $             0.34



    N/M































    Weighted average shares used in computing net (loss) income per Class A

       and B-1 common share:



























    Basic



    268,615



    265,918



    1 %



    267,549



    265,522



    1 %



    Diluted



    268,615



    266,297



    1 %



    267,549



    265,951



    1 %































     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except per share amounts)

    (Unaudited and subject to reclassification)











     February 3,

    2024 



     January 28,

    2023 

    ASSETS









    Current assets:









    Cash and cash equivalents



    $    125,428



    $    201,901

    Receivables, less allowance for credit losses1



    44,369



    49,580

    Merchandise inventories, net



    684,502



    652,430

    Prepaid expenses



    58,615



    51,274

    Other current assets



    38,830



    60,809

    Total current assets



    951,744



    1,015,994

    Fixed assets, net



    816,367



    803,327

    Operating lease right-of-use assets



    1,384,050



    1,397,761

    Goodwill



    980,297



    2,193,941

    Trade name



    1,025,000



    1,025,000

    Other long-term assets



    205,694



    176,806

    Total assets



    $ 5,363,152



    $ 6,612,829

    LIABILITIES AND EQUITY









    Current liabilities:









    Accounts payable and book overdrafts



    $    485,131



    $    381,213

    Accrued salaries and employee benefits



    101,265



    89,929

    Accrued expenses and other liabilities



    200,278



    217,556

    Current portion of operating lease liabilities



    310,507



    309,766

    Current portion of long-term debt and other lease liabilities



    15,962



    22,794

    Total current liabilities



    1,113,143



    1,021,258

    Senior secured credit facilities, net, excluding current portion



    1,576,223



    1,628,331

    Operating lease liabilities, excluding current portion



    1,116,615



    1,148,155

    Deferred taxes, net



    251,629



    303,121

    Other long-term liabilities



    121,113



    130,487

    Total liabilities



    4,178,723



    4,231,352

    Commitments and contingencies









    Stockholders' equity:









    Class A common stock2



    231



    228

    Class B-1 common stock3



    38



    38

    Class B-2 common stock4



    —



    —

    Preferred stock5



    —



    —

    Additional paid-in-capital



    2,229,582



    2,152,342

    (Accumulated deficit) retained earnings



    (1,047,243)



    232,967

    Accumulated other comprehensive income (loss)



    1,821



    (4,098)

    Total stockholders' equity



    1,184,429



    2,381,477

    Total liabilities and stockholders' equity



    $ 5,363,152



    $ 6,612,829





    (1)

    Allowances for credit losses are $1,806 and $952, respectively

    (2)

    Class A common stock, $0.001 par value: Authorized - 1.0 billion shares; Issued and outstanding - 231.2 million and 228.3 million shares, respectively

    (3)

    Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (4)

    Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (5)

    Preferred stock, $0.001 par value: Authorized - 25.0 million shares; Issued and outstanding - none

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited and subject to reclassification)















    53 Weeks

    Ended



    52 Weeks

    Ended





    February 3,

    2024



    January 28,

    2023

    Cash flows from operating activities:









    Net (loss) income



    $(1,280,210)



    $      89,910

    Adjustments to reconcile net (loss) income to net cash provided by

      operating activities:









    Depreciation and amortization



    200,782



    193,828

    Amortization of debt discounts and issuance costs



    4,972



    4,940

    Provision for deferred taxes



    (53,549)



    (893)

    Equity-based compensation expense



    81,859



    60,784

    Impairments, write-offs and losses on sale of fixed and other assets



    2,833



    1,992

    Loss on extinguishment and modification of debt



    920



    —

    Income from equity method investees



    (16,188)



    (12,976)

    Amounts reclassified out of accumulated other comprehensive income



    (488)



    168

    Goodwill impairment



    1,222,524



    —

    Non-cash operating lease costs



    429,056



    422,792

    Other non-operating (income) loss



    (4,727)



    12,667

    Changes in assets and liabilities:









    Receivables



    5,211



    6,038

    Merchandise inventories



    (32,072)



    22,681

    Prepaid expenses and other assets



    (8,009)



    (5,933)

    Accounts payable and book overdrafts



    103,919



    (22,763)

    Accrued salaries and employee benefits



    11,347



    (51,427)

    Accrued expenses and other liabilities



    (8,495)



    13,616

    Operating lease liabilities



    (446,981)



    (386,259)

    Other long-term liabilities



    3,015



    (3,162)

         Net cash provided by operating activities



    215,719



    346,003

    Cash flows from investing activities:









    Cash paid for fixed assets



    (225,598)



    (278,020)

    Cash paid for acquisitions, net of cash acquired



    (6,725)



    (9,640)

    Cash paid for interest in veterinary joint venture



    —



    (35,000)

    Proceeds from investment



    24,878



    —

    Proceeds from sale of assets



    —



    2,336

         Net cash used in investing activities



    (207,445)



    (320,324)

    Cash flows from financing activities:









    Borrowings under long-term debt agreements



    273,000



    123,000

    Repayments of long-term debt



    (348,000)



    (140,000)

    Payments for finance lease liabilities



    (5,925)



    (5,083)

    Proceeds from employee stock purchase plan and stock option exercises



    4,223



    3,796

    Tax withholdings on stock-based awards



    (8,650)



    (15,555)

         Net cash used in financing activities



    (85,352)



    (33,842)











    Net decrease in cash, cash equivalents and restricted cash



    (77,078)



    (8,163)

    Cash, cash equivalents and restricted cash at beginning of period



    213,727



    221,890

    Cash, cash equivalents and restricted cash at end of period



    $    136,649



    $    213,727

    NON-GAAP FINANCIAL MEASURES

    The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

    The tables below reflect the calculation of Adjusted EBITDA, Adjusted Net Income, and Adjusted EPS, as applicable, for the fourteen and fifty-three weeks ended February 3, 2024 compared to the thirteen and fifty-two weeks ended January 28, 2023, respectively.

    Adjusted EBITDA and Trailing Twelve Month Adjusted EBITDA

    Adjusted EBITDA, including Trailing Twelve Month Adjusted EBITDA, is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended January 28, 2023 filed with the SEC on March 28, 2023 for additional information on Adjusted EBITDA.

    (dollars in thousands)



    14 Weeks

    Ended



    13 Weeks

    Ended



    53 Weeks

    Ended



    52 Weeks

    Ended

    Reconciliation of Net (Loss) Income Attributable to Class A and B-1

       Common Stockholders to Adjusted EBITDA



    February 3,

    2024



    January 28,

    2023



    February 3,

    2024



    January 28,

    2023

    Net (loss) income attributable to Class A and B-1 common stockholders



    $      (22,575)



    $        32,732



    $    (1,280,210)



    $        90,801

    Add (deduct):

















    Interest expense, net



    39,332



    32,137



    147,504



    100,611

    Income tax (benefit) expense



    (10,435)



    14,548



    (27,613)



    35,347

    Depreciation and amortization



    52,189



    50,229



    200,782



    193,828

    Income from equity method investees



    (6,156)



    (5,155)



    (16,188)



    (12,976)

    Loss on debt extinguishment and modification



    —



    —



    920



    —

    Goodwill impairment



    —



    —



    1,222,524



    —

    Losses (gains) on sale of assets, impairments and write-offs



    631



    (307)



    2,833



    1,992

    Equity-based compensation expense



    17,428



    19,892



    81,859



    60,784

    Other non-operating loss (income)



    —



    3,298



    (4,727)



    12,667

    Mexico joint venture EBITDA (1)



    11,759



    9,265



    38,226



    29,584

    Acquisition-related integration costs (2)



    —



    627



    —



    15,314

    Other costs (3)



    23,167



    623



    35,193



    2,817

    Adjusted EBITDA



    $     105,340



    $    157,889



    $        401,103



    $     530,769

    Net sales



    $ 1,674,476



    $ 1,577,959



    $    6,255,284



    $ 6,035,967

    Net margin (4)



    (1.3 %)



    2.1 %



    (20.5 %)



    1.5 %

    Adjusted EBITDA Margin



    6.3 %



    10.0 %



    6.4 %



    8.8 %

    Adjusted Net Income and Adjusted EPS

    Adjusted Net Income and Adjusted diluted Earnings Per Share attributable to Petco common stockholders (Adjusted EPS) are considered non-GAAP financial measures under the SEC's rules because they exclude certain amounts included in the net income attributable to Petco common stockholders and diluted earnings per share attributable to Petco common stockholders calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they facilitate comparison of the current period performance with that of the comparable prior period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers to be Petco's core earnings performance as well as the ability to make a more informed assessment of such earnings performance with that of the prior period.

    (in thousands, except per share amounts)



    14 Weeks Ended



    13 Weeks Ended

    Reconciliation of Diluted EPS to Adjusted EPS



    February 3, 2024



    January 28, 2023





    Amount



    Per share



    Amount



    Per share

    Net (loss) income attributable to common stockholders / diluted EPS



    $          (22,575)



    $           (0.08)



    $           32,732



    $             0.12

    Add (deduct):

















    Income tax (benefit) expense



    (10,435)



    (0.04)



    14,548



    0.05

    Loss on debt extinguishment and modification



    —



    —



    —



    —

    Goodwill impairment



    —



    —



    —



    —

    Losses (gains) on sale of assets, impairments and write-offs



    631



    0.00



    (307)



    (0.00)

    Equity-based compensation expense



    17,428



    0.06



    19,892



    0.08

    Other non-operating loss



    —



    —



    3,298



    0.02

    Acquisition-related integration costs (2)



    —



    —



    627



    0.00

    Other costs (3)



    23,167



    0.09



    623



    0.00

    Adjusted pre-tax income / diluted earnings per share



    $          8,216



    $         0.03



    $        71,413



    $         0.27

    Income tax expense at 26% normalized tax rate



    2,136



    0.01



    18,567



    0.07

    Adjusted Net Income / Adjusted EPS



    $              6,080



    $             0.02



    $           52,846



    $             0.20

     

    (in thousands, except per share amounts)



    53 Weeks Ended



    52 Weeks Ended

    Reconciliation of Diluted EPS to Adjusted EPS



    February 3, 2024



    January 28, 2023





    Amount



    Per share



    Amount



    Per share

    Net (loss) income attributable to common stockholders / diluted EPS



    $   (1,280,210)



    $         (4.78)



    $         90,801



    $            0.34

    Add (deduct):

















    Income tax (benefit) expense



    (27,613)



    (0.10)



    35,347



    0.13

    Loss on debt extinguishment and modification



    920



    0.00



    —



    —

    Goodwill impairment



    1,222,524



    4.57



    —



    —

    Losses on sale of assets, impairments and write-offs



    2,833



    0.01



    1,992



    0.01

    Equity-based compensation expense



    81,859



    0.31



    60,784



    0.22

    Other non-operating (income) loss



    (4,727)



    (0.02)



    12,667



    0.05

    Acquisition-related integration costs (2)



    —



    —



    15,314



    0.06

    Other costs (3)



    35,193



    0.13



    2,817



    0.02

    Adjusted pre-tax income / diluted earnings per share



    $        30,779



    $         0.12



    $      219,722



    $         0.83

    Income tax expense at 26% normalized tax rate



    8,003



    0.03



    57,128



    0.22

    Adjusted Net Income / Adjusted EPS



    $         22,776



    $          0.09



    $       162,594



    $          0.61

    Free Cash Flow

    Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.

    The table below reflects the calculation of Free Cash Flow for the fourteen and fifty-three weeks ended February 3, 2024 compared to the thirteen and fifty-two weeks ended January 28, 2023, respectively.

    (in thousands)



    14 Weeks

    Ended



    13 Weeks

    Ended



    53 Weeks

    Ended



    52 Weeks

    Ended





    February 3,

    2024



    January 28,

    2023



    February 3,

    2024



    January 28,

    2023

    Net cash provided by operating activities



    $      47,023



    $    136,540



    $    215,719



    $    346,003

    Cash paid for fixed assets



    (49,066)



    (65,946)



    (225,598)



    (278,020)

    Free Cash Flow



    $         (2,043)



    $        70,594



    $         (9,879)



    $        67,983

    Non-GAAP Financial Measures Footnotes

    (1)

    Mexico Joint Venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.









    14 Weeks

    Ended



    13 Weeks

    Ended



    53 Weeks

    Ended



    52 Weeks

    Ended

    (in thousands)



    February 3,

    2024



    January 28,

    2023



    February 3,

    2024



    January 28,

    2023

    Net income



    $      12,311



    $      10,309



    $      32,375



    $      24,757

    Depreciation



    7,070



    5,954



    26,141



    19,820

    Income tax expense



    2,541



    1,065



    11,449



    9,409

    Foreign currency (gain) loss



    557



    (253)



    1,520



    (268)

    Interest expense, net



    1,039



    1,455



    4,966



    5,449

    EBITDA



    $      23,518



    $      18,530



    $      76,451



    $      59,167

    50% of EBITDA



    $       11,759



    $         9,265



    $       38,226



    $       29,584





    (2)

    Acquisition-related integration costs include direct costs resulting from acquiring and integrating businesses. These include third-party professional and legal fees and other integration-related costs that would not have otherwise been incurred as part of the company's operations.





    (3)

    Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.





    (4)

    We define net margin as net income attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-health--wellness-company-inc-reports-fourth-quarter-and-full-year-2023-earnings-302087395.html

    SOURCE Petco - Investor Relations

    Get the next $WOOF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WOOF

    DatePrice TargetRatingAnalyst
    7/19/2024$3.00 → $4.00Neutral
    Citigroup
    4/2/2024$5.00 → $1.50Buy → Underperform
    BofA Securities
    12/19/2023$3.11Hold
    Jefferies
    11/30/2023$8.00 → $3.00Outperform → Neutral
    Robert W. Baird
    11/29/2023Overweight → Equal Weight
    Wells Fargo
    9/29/2023Peer Perform
    Wolfe Research
    8/25/2023$10.00 → $7.00Outperform
    RBC Capital Mkts
    4/28/2023$10.00Hold
    Gordon Haskett
    More analyst ratings

    $WOOF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Anderson Joel D bought $4,717,461 worth of shares (1,586,088 units at $2.97) (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      4/1/25 7:14:43 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Breitner Cameron bought $2,354,325 worth of shares (750,000 units at $3.14) (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      5/29/24 7:35:36 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Briggs Gary S bought $99,924 worth of shares (30,000 units at $3.33), increasing direct ownership by 75% to 70,085 units (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      12/4/23 7:29:44 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Petco Health and Wellness Company Inc.

      DEFA14A - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

      5/30/25 4:33:19 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form DEF 14A filed by Petco Health and Wellness Company Inc.

      DEF 14A - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

      5/30/25 4:31:26 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Health and Wellness Company Inc. filed SEC Form 8-K: Leadership Update

      8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

      5/23/25 4:30:11 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Financials

    Live finance-specific insights

    See more
    • Petco Health and Wellness Company, Inc. to Host First Quarter 2025 Earnings Conference Call on June 5, 2025

      SAN DIEGO, May 15, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced that its financial results for the first quarter fiscal 2025 will be released after market close on Thursday, June 5, 2025. The company will host a conference call at 4:30 p.m. Eastern time to discuss the results. A live webcast of the conference call will be available on the company's Investor Relations page at https://ir.petco.com/news-and-events/events-and-presentations. A replay of the webcast will be available through the same link approximately two hours after t

      5/15/25 4:05:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

      Expects Double-Digit Adjusted EBITDA Growth in 2025* SAN DIEGO, March 26, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced its fourth quarter and full year 2024 financial results. Q4 2024 Overview Net revenue of $1.6 billion decreased 7.3% year over year inclusive of the negative impact from the loss of the 53rd week in 2023Comparable sales increased 0.5% year over yearGross profit of $589.3 million decreased 2.8% year over year compared to $606.3 million last yearGAAP net loss of $13.8 million compared to GAAP net loss of $22.6 millio

      3/26/25 4:02:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Health and Wellness Company, Inc. to Host Fourth Quarter 2024 Earnings Conference Call on March 26, 2025

      SAN DIEGO, Feb. 20, 2025 /PRNewswire/ -- On March 26, 2025, at approximately 4:00 p.m. Eastern, Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), a complete partner in pet health and wellness, will release its fourth quarter 2024 earnings results and full-year fiscal 2025 outlook. Additionally, Petco executives will host a conference call at approximately 4:30 p.m. Eastern to review the company's financial and operating performance. The call will be webcast live and the earnings release and earnings presentation will be available on the company's Investor Relations page a

      2/20/25 4:00:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Anderson Joel D was granted 5,000 shares, increasing direct ownership by 0.16% to 3,225,181 units (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      5/6/25 6:17:14 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Officer Insana Giovanni covered exercise/tax liability with 49,948 shares, decreasing direct ownership by 10% to 470,147 units (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      4/17/25 6:28:39 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Chief Human Resources Officer May Holly covered exercise/tax liability with 146,204 shares, decreasing direct ownership by 7% to 2,021,388 units (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      4/17/25 6:27:08 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Citigroup reiterated coverage on Petco Health and Wellness with a new price target

      Citigroup reiterated coverage of Petco Health and Wellness with a rating of Neutral and set a new price target of $4.00 from $3.00 previously

      7/19/24 8:30:14 AM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Health and Wellness downgraded by BofA Securities with a new price target

      BofA Securities downgraded Petco Health and Wellness from Buy to Underperform and set a new price target of $1.50 from $5.00 previously

      4/2/24 7:46:18 AM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Jefferies initiated coverage on Petco Health and Wellness with a new price target

      Jefferies initiated coverage of Petco Health and Wellness with a rating of Hold and set a new price target of $3.11

      12/19/23 6:54:34 AM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

      SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

      2/14/24 12:55:28 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

      SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

      2/14/24 6:00:20 AM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form SC 13G filed by Petco Health and Wellness Company Inc.

      SC 13G - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

      2/14/22 4:43:20 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Petco Health and Wellness Company, Inc. to Host First Quarter 2025 Earnings Conference Call on June 5, 2025

      SAN DIEGO, May 15, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced that its financial results for the first quarter fiscal 2025 will be released after market close on Thursday, June 5, 2025. The company will host a conference call at 4:30 p.m. Eastern time to discuss the results. A live webcast of the conference call will be available on the company's Investor Relations page at https://ir.petco.com/news-and-events/events-and-presentations. A replay of the webcast will be available through the same link approximately two hours after t

      5/15/25 4:05:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco joins Uber Eats for Nationwide On-Demand Delivery

      Today Uber Technologies, Inc. (NYSE:UBER) and Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) announced a new partnership that brings Petco's wide selection of pet essentials to the Uber Eats platform, making it easier than ever for pet parents to get what they need, when they need it. With all Petco locations in the contiguous United States now available on Uber Eats, customers can shop for on-demand or scheduled delivery of pet food, toys, treats, and other essentials—all at the tap of a button. Starting today, pet parents can browse and purchase Petco's curated assortment of high-quality products directly through the Uber Eats app, with convenient delivery options that fit their b

      3/27/25 9:00:00 AM ET
      $UBER
      $WOOF
      Business Services
      Consumer Discretionary
      Other Specialty Stores
    • Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

      Expects Double-Digit Adjusted EBITDA Growth in 2025* SAN DIEGO, March 26, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced its fourth quarter and full year 2024 financial results. Q4 2024 Overview Net revenue of $1.6 billion decreased 7.3% year over year inclusive of the negative impact from the loss of the 53rd week in 2023Comparable sales increased 0.5% year over yearGross profit of $589.3 million decreased 2.8% year over year compared to $606.3 million last yearGAAP net loss of $13.8 million compared to GAAP net loss of $22.6 millio

      3/26/25 4:02:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Leadership Updates

    Live Leadership Updates

    See more
    • PETCO STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF THREE PROVEN EXECUTIVES

      Sabrina Simmons Appointed Chief Financial Officer Michael Romanko Appointed Chief Customer and Product Officer Jack Stout Appointed Chief Merchandising Officer SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced the appointment of three new leaders to Petco's executive team to support accelerated operational improvement and position the business for a faster return to profitable growth. Sabrina Simmons, former Chief Financial Officer at Gap, Inc., has been named Chief Financial Officer, effective February 17.Michael

      2/18/25 4:10:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Names Joe Venezia Chief Revenue Officer

      SAN DIEGO, Nov. 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced Joe Venezia will join the company as Chief Revenue Officer, effective Nov. 17, reporting to Joel Anderson, Chief Executive Officer. In this newly created role, Venezia will be responsible for driving revenue and developing integrated strategies to improve the customer experience. Joe will oversee critical areas that contribute to Petco's growth, including pet care centers, pet and veterinary services, real estate and customer success capabilities. "Joe is a proven sal

      11/13/24 8:02:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Names Joel D. Anderson as Chief Executive Officer

      30-Year Retail Industry Veteran Named Chief Executive Officer and Member of the Board of Directors R. Michael Mohan to Lead a New Board Committee Focused on Value Creation SAN DIEGO, July 17, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced that the Company's Board of Directors has appointed Joel D. Anderson to serve as Chief Executive Officer (CEO), effective July 29, 2024. In addition, Anderson has been elected to serve on the Company's Board of Directors. "Joel is an inspirational leader and a highly experienced retail CEO," said Gl

      7/17/24 4:02:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary